Allurion Technologies Inc.

ALUR ·Healthcare, Medical Devices, United States
Valuation › AI Valuation

AI Valuation

AI-generated fair value estimate for this company.

AI Fair Value $0.10
Market Price $0.60
Overvalued By 500.0%

Method: Distressed EV/sales less net debt: $15.2M FY2025 revenue (down 52.6% YoY) at a 0.3x depressed sales multiple implies ~$4.6M enterprise value; against $76.7M total debt and only $5.4M cash (~$71.3M net debt); 617,410 shares outstanding post 2025 reverse split.

Reasoning: Revenue collapse and total debt far exceeding a reasonable enterprise value leave common equity holders with only nominal option value; going-concern and further-dilution risk are high for this bariatric device maker.